OECD-based pricing guideline should be introduced, lawmaker suggests

The government needs to re-evaluate the current pricing-set system of reimbursable drugs and introduce a new OECD-based pricing guideline to discourage the increasing prescription patter toward high-priced drug and protect the domestic pharmaceutical industry, said Rep. Hyun Ae-ja of Democratic Labor Party.

In the recent parliamentary inspection to the Health Insurance Review Agency, she sai...